Kiniksa Pharmaceuticals International, plc
KNSA
Clasificación en acciones
#2917
Kiniksa Pharmaceuticals International, plc, a biopharmaceutical company,... Kiniksa Pharmaceuticals International, plc, a biopharmaceutical company, develops and commercializes medical therapies in the United States, the United Kingdom, and internationally. The company offers ARCALYST, an interleukin-1alpha and 1beta cytokine trap for the treatment of recurrent pericarditis, a chronic autoinflammatory cardiovascular disease and cardiac sarcoidosis. It also develops KPL-387, an investigational and fully human immunoglobulin G2 monoclonal antibody, which is Phase 2/3 clinical trial for the treatment of recurrent pericarditis; and KPL-116, a Fc-modified immunoglobulin G2 monoclonal antibody, which is in pre-clinical stage. The company was formerly known as Kiniksa Pharmaceuticals, Ltd. and changed its name to Kiniksa Pharmaceuticals International, plc in June 2024. Kiniksa Pharmaceuticals International, plc was incorporated in 2015 and is based in London, the United Kingdom.
Precio por acción
$80.10
Última sincronización: 2026-10-21
Capitalización bursátil
$6.25B
Cambio (1 día)
-3.69%
Cambio (1 año)
105.92%
País
GB
Comercio Kiniksa Pharmaceuticals International, plc (KNSA)
Categoría
Healthcare
Historial del precio de la acción de Kiniksa Pharmaceuticals International, plc (KNSA)
Precio más alto de cierre: $78.59 el 2026-10-01
Precio más bajo de cierre: $18.08 el 2018-05-01
Precio más bajo de cierre: $18.08 el 2018-05-01
Historial del precio de la acción de Kiniksa Pharmaceuticals International, plc desde 2018 hasta 2026
Desempeño anual del precio de la acción
| Año | Rendimiento |
|---|---|
| 2026 (TTM) | 31.83% |
| 2025 | 101.55% |
| 2024 | 16.14% |
| 2023 | 13.98% |
| 2022 | 22.63% |
| 2021 | -31.53% |
| 2020 | 57.49% |
| 2019 | -47.95% |
| 2018 | 0.00% |
Precio de la acción de empresas similares o competidoras
| Empresa | Precio de la acción | Cambio 1a% | País |
|---|---|---|---|
| $62.20 | 68.82% |
US
|
|
| $45.36 | 35.06% |
SE
|
|
| $169.58 | 22.61% |
FR
|
|
| $116.39 | 58.03% |
US
|
|
| $59.46 | -0.57% |
IT
|
